1) mutant p53
突变型p53
1.
Correlation and potential interaction between FHIT and mutant P53 expression in non-small cell lung cancer;
非小细胞肺癌组织FHIT和突变型P53表达的关联性及相互作用
2.
Effects of Baicao Jiangzhiling on the Expression of PCNA and Mutant p53 in the Atherosclerotic Rabbit;
百草降脂灵对动脉粥样硬化兔腹主动脉PCNA及突变型p53表达的影响
3.
The expression and clinical significance of mutant p53,bcl-2,Ki-67,survivin in non-Hodgkin' s lymphoma(NHL)
非霍奇金淋巴瘤组织中突变型p53、bcl-2、Ki-67及survivin蛋白表达及临床意义
2) mtP53
突变型P53
1.
Expression of PTEN and mtP53 Gene in epithelial ovarian cancer.;
上皮性卵巢癌磷酸酶-张力蛋白和突变型P53表达的临床意义
3) mutable p53 protein
突变型p53蛋白
1.
The relationship between the expression of mutable p53 protein in the population at high risk gastric cancer and helicobacter pylori infection;
陕北胃癌高危人群胃粘膜组织中突变型p53蛋白的表达与Hp感染的关系
2.
The Relationship The Expression of mutable P53 protein in the different pathological tissue of Gastric Mucosa;
胃黏膜不同病变组织中突变型P53蛋白表达的研究
3.
[Purpose] To investigate the expressions of cyclooxygenase-2 (COX-2) protein and mutable p53 protein in the patients with breast cancer and their relationship to clinicopathological factors.
目的:运用链霉菌抗生物素蛋白-过氧化物酶免疫组织化学方法(简称s-p法)检测COX-2蛋白和突变型p53蛋白在乳腺癌组织中的表达情况,探讨二者在乳腺癌发生、发展中的作用、相互关系及与临床病理学特征之间的关系。
4) mutation p53 gene
突变型p53基因
1.
AIM: To establish bi-transgenic mice models containing mutation p53 gene and Epstein-Barr (EB) virus latent membrane protein 1 gene (LMP1) and to provide reliable tools for studying the reciprocity of mutant p53 with LMP1 in the tumorogenesis process of nasopharyngeal precancerosis.
方法:通过分子克隆技术构建含突变型p53基因和EB病毒LMP1基因的真核表达载体pLMP1-p53mt;采用显微注射法将线性化的表达载体注射至小鼠受精卵的雄性原核中,然后将注射存活的受精卵植入假孕母鼠的输卵管;取其产3wk龄子代鼠进行PCR初选,再通过Southern杂交进一步确证;利用HE染色法观察4mo龄转基因小鼠不同组织病理变化。
2.
[Objective] To construct eukaryotic expression plasmid containing mutation p53 gene and Epstein-Barr virus latent membrane protein 1 gene (LMP1) so that the reciprocity of mutation p53 with LMP1 in the tumorogenesis process of nasopharyngeal carcinoma could be investigated more easily.
目的构建含突变型p53基因和EB病毒LMP1基因的双基因真核表达质粒,为研究突变型p53基因和EB病毒LMP1基因在鼻咽癌发生中的相互作用奠定基础。
5) mutant p53 protein
突变型p53蛋白
1.
Objective To detect the change of mutant P53 protein in cervical cancer before and after arterial interventional chemotherapy and to investigate the relationship between the protein and resistance to chemotherapeutics , therapeutic effect of arterial interventional chemotherapy.
目的 检测宫颈癌组织中突变型P53蛋白在动脉介入化疗前后的变化，探讨其与宫颈癌组织化疗药物抵抗以及动脉介入化疗疗效的关系。
6) Gene mutant p53
基因突变型p53
补充资料：tRNA突变型
tRNA突变型
tRNA的反密码子发生变化的突变型。也就是一种移码突变抑制基因或一个终链突变抑制基因；也可以是tRNA基因发生突变的结果，或某一种酶的结构基因突变的结果。这种酶具有改变tRNA结构的作用。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条